ReVision Wellness

ReVision Wellness · 11312 Manklin Creek Rd · Berlin, MD 21811

5.0· 153 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

ReVision Wellness is a health and wellness practice in Berlin, Maryland, which its website says is led by Angela Borrell and offers holistic health services for the Ocean City area. The site describes comprehensive health assessments and personalized treatment plans delivered by licensed healthcare professionals. On Google it has a 5.0-star rating across 153 reviews dating back to 2021, with 14 posted in the past year. Reviewers most often mention the staff and the providers' knowledge, and 7 reviews mention scheduling.

Services & access

Advertises semaglutide today	Not listed
Advertises tirzepatide today	Not listed
Telehealth visits	Not listed
Cash pay accepted	Yes
Accepts insurance — per practice website	Yes
Accepting new patients — per practice website	Yes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0

Google rating · 153 reviews

reviews in the past year (avg ★ 5.0)

reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-08-10. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 153 Google reviews. Of the 100 reviews we analyzed, 99 (99%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

Friendly, helpful staff27 reviews
Knowledgeable, professional providers18 reviews
Easy scheduling and communication7 reviews
Feeling listened to6 reviews

Common complaints

No negative reviews among those we analyzed.

5★

4★

3★

2★

1★

Most recent Google reviews

Delena B.★★★★★2026-08-10
I've been with this company since I started using medical mauryana .I love them it's easy and they respond to you right away! I encouraged my friends to try them!

Tommy H.★★★★★2026-07-17
Great people aways there to help highly recommended

Marc S.★★★★★2026-07-13
FANTASTIC EXPERIENCE!!!!! First time customer and it was an extremely easy process! Less than 10 minutes overall and BEST PRICE

Robert★★★★★2026-07-02
The guy that assisted me was very helpful and resolved my issues. Thank you for your patience

Marlenn M.★★★★★2026-06-30
I do my recertification every year them them & it is so quick and easy and the people are so nice and understanding!! Definitely recommend!! They are also always on time and so nice!

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Berlin

Sustainable Nutrition

617 Franklin Avenue · Berlin, MD 21811

5.0(28 Google reviews)

Accepts insurance

View profile Visit website

Listing updated Oct 2, 2026

Retatrutide status

Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development: Phase 3 complete
FDA status: Submission planned — Q1 2027 (Lilly guidance)
Availability: Not commercially available
Access routes: Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs